Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Mary W. Kearns is active.

Publication


Featured researches published by Mary W. Kearns.


Journal of Biological Chemistry | 2001

Protein Kinases C Translocation Responses to Low Concentrations of Arachidonic Acid

Joseph T. O'Flaherty; Brad A. Chadwell; Mary W. Kearns; Susan Sergeant; Larry W. Daniel

Arachidonic acid (AA) directly activates protein kinases C (PKC) and may thereby serve as a regulatory signal during cell stimulation. The effect, however, requires a ≥20 μm concentration of the fatty acid. We find that human polymorphonuclear neutrophils (PMN) equilibrated with a ligand for the diacylglycerol receptor on PKC, [3H]phorbol dibutyrate (PDB), increased binding of [3H]PDB within 15 s of exposure to ≥10–30 nm AA. Other unsaturated fatty acids, but not a saturated fatty acid, likewise stimulated PDB binding. These responses, similar to those caused by chemotactic factors, resulted from a rise in the number of diacylglycerol receptors that were plasma membrane-associated and therefore accessible to PDB. Unlike chemotactic factors, however, AA was fully active on cells overloaded with Ca2+chelators. The major metabolites of AA made by PMN, leukotriene B4 and 5-hydroxyicosatetraenoate, did not mimic AA, and an AA antimetabolite did not block responses to AA. AA also induced PMN to translocate cytosolic PKCα, βII, and δ to membranes. This response paralleled PDB binding with respect to dose requirements, time, Ca2+-independence, resistance to an AA antimetabolite, and induction by another unsaturated fatty acid but not by a saturated fatty acid. Finally, HEK 293 cells transfected with vectors encoding PKCβI or PKCδ fused to the reporter enhanced green fluorescent protein (EGFP) were studied. AA caused EGFP-PKCβ translocation from cytosol to plasma membrane at ≥0.5 μm, and EGFP-PKCδ translocation from cytosol to nuclear and, to a lesser extent, plasma membrane at as little as 30 nm. We conclude that AA induces PKC translocations to specific membrane targets at concentrations 2–4 orders of magnitude below those activating the enzymes. These responses, at least as they occur in PMN, do not require changes in cell Ca2+ or oxygenation of the fatty acid. AA seems more suited for signaling the movement than activation of PKC.


Journal of Biological Chemistry | 1997

Alteration in Apolipoprotein A-I 22-Mer Repeat Order Results in a Decrease in Lecithin:Cholesterol Acyltransferase Reactivity

Mary G. Sorci-Thomas; Linda K. Curtiss; John S. Parks; Michael J. Thomas; Mary W. Kearns

Apolipoprotein A-I contains eight 22-amino acid and two 11-amino acid tandem repeats that comprise 80% of the mature protein. These repeating units are believed to be the basic motif responsible for lipid binding and lecithin:cholesterol acyltransferase (LCAT) activation. Computer analysis indicates that despite a fairly high degree of compositional similarity among the tandem repeats, significant differences in hydrophobic and amphipathic character exist. Our previous studies demonstrated that deletion of repeat 6 (143-164) or repeat 7 (165-186) resulted in a 98-99% reduction of LCAT activation as compared with wild-type apoA-I. To determine the effects of substituting one of these repeats with a more hydrophobic repeat we constructed a mutant apoA-I protein in which residues 143-164 (repeat 6) were replaced with repeat 10 (residues 220-241). The cloned mutant protein, 10F6 apoA-I, was expressed and purified from an Sf-9 cell baculoviral system and then analyzed using a number of biophysical and biochemical techniques. Recombinant complexes prepared at a 100:5:1 molar ratio of L-α-dimyristoylphosphatidylcholine:cholesterol:wild-type or 10F6 apoA-I showed a doublet corresponding to Stokes diameters of 114 and 108 Å on nondenaturing 4-30% polyacrylamide gel electrophoresis. L-α-Dimyristoylphosphatidylcholine 10F6 apoA-I complexes had a 5-6-fold lower apparent Vmax/apparent Km as compared with wild-type apoA-I containing particles. As expected, monoclonal antibody epitope mapping of the lipid-free and lipid-bound 10F6 apoA-I confirmed that a domain expressed between residues 143 and 165 normally found in wild-type apoA-I was absent. The region between residues 119 and 144 in 10F6 apoA-I showed a marked reduction in monoclonal antibody binding capacity. Therefore, we speculate that the 5-6-fold lower LCAT reactivity in 10F6 compared with wild-type apoA-I recombinant particles results from increased stabilization within the 121-165 amino acid domain due to more stable apoprotein helix phospholipid interactions as well as from conformational alterations among adjacent amphipathic helix repeats.


Journal of Biological Chemistry | 1993

Apolipoprotein A-I domains involved in lecithin-cholesterol acyltransferase activation. Structure:function relationships.

Mary G. Sorci-Thomas; Mary W. Kearns; J P Lee


Journal of Biological Chemistry | 1998

The Hydrophobic Face Orientation of Apolipoprotein A-I Amphipathic Helix Domain 143–164 Regulates Lecithin:Cholesterol Acyltransferase Activation

Mary G. Sorci-Thomas; Linda K. Curtiss; John S. Parks; Michael J. Thomas; Mary W. Kearns; Mark Landrum


Journal of Lipid Research | 1996

High level secretion of wild-type and mutant forms of human proapoA-I using baculovirus-mediated Sf-9 cell expression.

Mary G. Sorci-Thomas; John S. Parks; Mary W. Kearns; G N Pate; C Zhang; Michael J. Thomas


Journal of Lipid Research | 1992

HepG2 cell LDL receptor activity and the accumulation of apolipoprotein B and E in response to docosahexaenoic acid and cholesterol

Mary G. Sorci-Thomas; Cynthia L. Hendricks; Mary W. Kearns


Biochimica et Biophysica Acta | 2004

Differential role for phospholipase D1 and phospholipase D2 in 12-O-tetradecanoyl-13-phorbol acetate-stimulated MAPK activation, Cox-2 and IL-8 expression

Leslie T Grab; Mary W. Kearns; Andrew J. Morris; Larry W. Daniel


Journal of Biological Chemistry | 1991

Transcriptional regulation of the apolipoprotein A-I gene. Species-specific expression correlates with rates of gene transcription.

Mary G. Sorci-Thomas; Mary W. Kearns


Biochimica et Biophysica Acta | 1995

Species-specific polymorphism in the promoter of the apolipoprotein A-I gene: restoration of human transcriptional efficiency by substitution at positions −189, −144 and −48 bp

Mary G. Sorci-Thomas; Mary W. Kearns


Biophysical Journal | 2017

Hydration Control in Brain Extracellular Matrix:Astrocytes, Perycites, and Fibroblasts Adjust their Contractile Responses to Local Water Activity

Maria P. McGee; Mary W. Kearns; Michael J. Morykwas; Louis C. Argenta

Collaboration


Dive into the Mary W. Kearns's collaboration.

Top Co-Authors

Avatar

Mary G. Sorci-Thomas

Medical College of Wisconsin

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Michael J. Thomas

Medical College of Wisconsin

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Linda K. Curtiss

Scripps Research Institute

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Andrew J. Morris

University of North Carolina at Chapel Hill

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge